8PX2
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1,3-dimethyl-5-(1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-09-12 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 71.949, 52.631, 32.159 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.442 - 1.622 |
Rwork | 0.152 |
R-free | 0.17690 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.003 |
RMSD bond angle | 1.044 |
Data reduction software | XDS |
Data scaling software | Aimless |
Refinement software | REFMAC (5.8.0352) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 71.950 | 1.710 |
High resolution limit [Å] | 1.620 | 1.620 |
Rmerge | 0.024 | 0.170 |
Number of reflections | 15520 | 1903 |
<I/σ(I)> | 26.6 | 5.6 |
Completeness [%] | 96.7 | 83.6 |
Redundancy | 2.7 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 293 | 30% PEG 300, 0.1M MES buffer pH6.5 |